- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02236780
Influence of Environmental Conditions on In Vitro Fertilization (IVF) Attempts and Induced Pregnancies (MeteoFIV)
The main purpose of the study is to assess the impact of environmental conditions on live-birth rates after intraconjugal IVF.
The second purposes are
- to assess the impact on pregnancies (prematurity, preeclampsia);
- to assess the impact on newborn's health (stunted growth);
- to evaluate the consistency of results observed between assisted pregnancies and spontaneous pregnancies.
Study Overview
Status
Conditions
Detailed Description
This multicenter epidemiological study aims to analyze the individual standardized clinical records, collected prospectively since 2008 in the medically assisted procreation centers (MAP).
These individual data will be mapped to the environmental data (meteorological and air quality), recorded in the area of residence of the mother at the time of conception and pregnancy, as well as to the socio-economic data.
Choice of centers:
- The study will be proposed to the 106 private or public centers in metropolitan France who are authorized for MAP procedures such as IVF and ICSI.
- Only the centers who perform more than 200 oocyte retrievals per year will be selected to participate in the study.
More than 80% of attempts performed by the selected centers should be available (without missing data) on the induced pregnancies and their outcome (minimum data set for each case: age of man and woman, cause of infertility, technique used, sperm collection method (ejaculation, surgical sperm retrieval techniques), total number of embryos obtained, clinical pregnancy or not, term of pregnancy, weight and height of the child at birth).
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Hauts-de-seine
-
Boulogne-Billancourt, Hauts-de-seine, France, 92100
- Recruiting
- Alain BEAUCHET
-
Contact:
- Alain BEAUCHET, MD
- Phone Number: + 33 (0)1 49 09 56 68
- Email: alain.beauchet@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Intraconjugal IVF and ICSI
- Transfers of frozen embryos after intraconjugal IVF or ICSI
Exclusion Criteria:
- IVF and ICSI with sperm donation
- IVF and ICSI with egg donation
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Live birth rate
Time Frame: 1 year
|
Live birth rate after intraconjugal IVF (IVF and ICSI) by oocyte retrieval and by embryo transfer.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fertilization rate
Time Frame: 1 year
|
Rate of fertilization (IVF and ICSI), rate of good quality embryos, rate of blastoformation (if prolonged culture), rate of embryo freezing.
|
1 year
|
|
Rates of clinical pregnancy
Time Frame: 1 year
|
Rates of assisted pregnancy, rate of spontaneous miscarriage, rate of medical termination of pregnancy, rate of pathology of pregnancy (pre-eclampsia, gestational diabetes, placenta praevia, signs of preterm labor with hospitalization).
|
1 year
|
|
Fetal growth restriction rate
Time Frame: 1 year
|
Fetal growth restriction rate, biometrics of child at birth (height, weight, head circumference, Body Mass Index), preterm birth rate, transfer rate to intensive care units.
|
1 year
|
|
Effect sizes and periods of susceptibility to environmental conditions
Time Frame: 5 years
|
Effect sizes and periods of susceptibility to environmental conditions among assisted pregnancies and spontaneous pregnancies.
|
5 years
|
Collaborators and Investigators
Investigators
- Study Director: Philippe AEGERTER, MD, PhD, Hôpital Ambroise Paré, AP-HP
- Study Chair: Alain BEAUCHET, MD, Hôpital Ambroise Paré, AP-HP
- Study Director: Rachel LEVY, MD, PhD, Hôpital Jean Verdier, AP-HP
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AOR13130
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on In Vitro Fertilisation
-
Ibn Sina HospitalBanon IVF Center Assiut, Egypt; Egyptian IVF CenterCompleted
-
Universitas PadjadjaranCompleted
-
Mỹ Đức HospitalCompletedLuteal Phase | in Vitro FertilisationVietnam
-
Ferring PharmaceuticalsCompletedIn Vitro Fertilisation (IVF) TreatmentCzechia, Belgium, Spain
-
Ferring PharmaceuticalsCompletedIn Vitro Fertilisation (IVF) TreatmentBelgium, Czechia, Spain
-
University of Central FloridaThe IVF Center at Winter ParkRecruitingInVitro Fertilization | In Vitro Fertilisation (IVF) Treatment | Ovarian Aging | In Vitro Fertilization OutcomeUnited States
-
Nova Clinic, RussiaUnknownInfertility, Female | Ovarian Stimulation | In Vitro FertilisationRussian Federation
-
University of ManchesterNot yet recruitingInfertility | Assisted Reproductive Technology | Cardiovascular Health | Metabolic Health | in Vitro Fertilisation | Maternal Cardiometabolic Health
-
Istanbul University - CerrahpasaNot yet recruitingInfertility | Failed in Vitro Fertilisation
-
Karolinska InstitutetCentre Leon Berard; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsNot yet recruitingQuality of Life | Cancer | Infertility | In Vitro Fertilisation (IVF) Treatment | Late Effects | Cancer in Pregnancy | POI | Sexual Health Quality of Life | Contraception Use